300 related articles for article (PubMed ID: 21555868)
1. Pneumocyte biomarkers KL-6 and surfactant protein D reflect the distinct findings of high-resolution computed tomography in nonspecific interstitial pneumonia.
Ichiyasu H; Ichikado K; Yamashita A; Iyonaga K; Sakamoto O; Suga M; Kohrogi H
Respiration; 2012; 83(3):190-7. PubMed ID: 21555868
[TBL] [Abstract][Full Text] [Related]
2. Serum KL-6 in fibrotic NSIP: Correlations with physiologic and radiologic parameters.
Sakamoto K; Taniguchi H; Kondoh Y; Johkoh T; Sumikawa H; Kimura T; Nishiyama O; Kato K; Kataoka K; Ono K; Kitaichi M; Hasegawa Y
Respir Med; 2010 Jan; 104(1):127-33. PubMed ID: 19811899
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of changes in the serum levels of Krebs von den Lungen-6 and surfactant protein-D over time as important biomarkers in idiopathic fibrotic nonspecific interstitial pneumonia.
Yamakawa H; Hagiwara E; Ikeda S; Iwasawa T; Otoshi R; Tabata E; Okuda R; Sekine A; Baba T; Iso S; Okudela K; Takemura T; Ogura T
Respir Investig; 2019 Sep; 57(5):422-429. PubMed ID: 31003951
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the Diagnostic Efficacies of Serological Markers KL-6, SP-A, SP-D, CCL2, and CXCL13 in Idiopathic Interstitial Pneumonia.
Xue M; Guo Z; Cai C; Sun B; Wang H
Respiration; 2019; 98(6):534-545. PubMed ID: 31665737
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of serum KL-6 and SP-D for the diagnosis and treatment of interstitial lung disease in patients with diffuse connective tissue disorders].
Ogawa N; Shimoyama K; Kawabata H; Masaki Y; Wano Y; Sugai S
Ryumachi; 2003 Feb; 43(1):19-28. PubMed ID: 12692986
[TBL] [Abstract][Full Text] [Related]
6. Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma.
Hant FN; Ludwicka-Bradley A; Wang HJ; Li N; Elashoff R; Tashkin DP; Silver RM;
J Rheumatol; 2009 Apr; 36(4):773-80. PubMed ID: 19286849
[TBL] [Abstract][Full Text] [Related]
7. Marked increase in serum KL-6 and surfactant protein D levels during the first 4 weeks after treatment predicts poor prognosis in patients with active interstitial pneumonia associated with polymyositis/dermatomyositis.
Arai S; Kurasawa K; Maezawa R; Owada T; Okada H; Fukuda T
Mod Rheumatol; 2013 Sep; 23(5):872-83. PubMed ID: 22983659
[TBL] [Abstract][Full Text] [Related]
8. Surfactant protein D and KL-6 serum levels in systemic sclerosis: correlation with lung and systemic involvement.
Bonella F; Volpe A; Caramaschi P; Nava C; Ferrari P; Schenk K; Ohshimo S; Costabel U; Ferrari M
Sarcoidosis Vasc Diffuse Lung Dis; 2011 Jul; 28(1):27-33. PubMed ID: 21796888
[TBL] [Abstract][Full Text] [Related]
9. The radiological patterns of interstitial change at an early phase: over a 4-year follow-up.
Tsushima K; Sone S; Yoshikawa S; Yokoyama T; Suzuki T; Kubo K
Respir Med; 2010 Nov; 104(11):1712-21. PubMed ID: 20538446
[TBL] [Abstract][Full Text] [Related]
10. Surfactant protein-D is more useful than Krebs von den Lungen 6 as a marker for the early diagnosis of interstitial pneumonitis during pegylated interferon treatment for chronic hepatitis C.
Ishikawa T; Kubota T; Abe H; Hirose K; Nagashima A; Togashi T; Seki K; Honma T; Yoshida T; Kamimura T
Hepatogastroenterology; 2012 Oct; 59(119):2260-3. PubMed ID: 23435141
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive investigation of novel serum markers of pulmonary fibrosis associated with systemic sclerosis and dermato/polymyositis.
Kumánovics G; Minier T; Radics J; Pálinkás L; Berki T; Czirják L
Clin Exp Rheumatol; 2008; 26(3):414-20. PubMed ID: 18578962
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic nonspecific interstitial pneumonia: changes in high-resolution computed tomography on long-term follow-up.
Kim MY; Song JW; Do KH; Jang SJ; Colby TV; Kim DS
J Comput Assist Tomogr; 2012; 36(2):170-4. PubMed ID: 22446354
[TBL] [Abstract][Full Text] [Related]
13. Performance of Candidate Serum Biomarkers for Systemic Sclerosis-Associated Interstitial Lung Disease.
Elhai M; Hoffmann-Vold AM; Avouac J; Pezet S; Cauvet A; Leblond A; Fretheim H; Garen T; Kuwana M; Molberg Ø; Allanore Y
Arthritis Rheumatol; 2019 Jun; 71(6):972-982. PubMed ID: 30624031
[TBL] [Abstract][Full Text] [Related]
14. [Assessment of serum markers KL-6 and SP-D for interstitial pneumonia associated with connective tissue diseases].
Suematsu E; Miyamura T; Shimada H; Nakao R; Yamamoto M
Ryumachi; 2003 Feb; 43(1):11-8. PubMed ID: 12692985
[TBL] [Abstract][Full Text] [Related]
15. Impact of anti-tumor necrosis factor-α agents on serum levels of KL-6 and surfactant protein-D in patients with psoriasis.
Hayashi M; Yanaba K; Umezawa Y; Asahina A; Nakagawa H
J Dermatol; 2017 Sep; 44(9):1063-1066. PubMed ID: 28370220
[TBL] [Abstract][Full Text] [Related]
16. Serum concentrations of Krebs von den Lungen-6, surfactant protein D, and matrix metalloproteinase-2 as diagnostic biomarkers in patients with asbestosis and silicosis: a case-control study.
Xue C; Wu N; Li X; Qiu M; Du X; Ye Q
BMC Pulm Med; 2017 Nov; 17(1):144. PubMed ID: 29149883
[TBL] [Abstract][Full Text] [Related]
17. [A high-resolution CT and pathological study of nonspecific interstitial pneumonia].
Cai HR; Dai LJ; Cao M; Meng FQ; Wei JY
Zhonghua Jie He He Hu Xi Za Zhi; 2008 Jan; 31(1):32-6. PubMed ID: 18366904
[TBL] [Abstract][Full Text] [Related]
18. Usual interstitial pneumonia and chronic idiopathic interstitial pneumonia: analysis of CT appearance in 92 patients.
Sumikawa H; Johkoh T; Ichikado K; Taniguchi H; Kondoh Y; Fujimoto K; Tateishi U; Hiramatsu T; Inoue A; Natsag J; Ikemoto M; Mihara N; Honda O; Tomiyama N; Hamada S; Nakamura H; Müller NL
Radiology; 2006 Oct; 241(1):258-66. PubMed ID: 16908678
[TBL] [Abstract][Full Text] [Related]
19. Lung ultrasound B-lines and serum KL-6 correlate with the severity of idiopathic inflammatory myositis-associated interstitial lung disease.
Wang Y; Chen S; Lin J; Xie X; Hu S; Lin Q; Zheng K; Du G; Huang X; Zhang G; Gargani L; Matucci-Cerinic M; Furst DE
Rheumatology (Oxford); 2020 Aug; 59(8):2024-2029. PubMed ID: 31794028
[TBL] [Abstract][Full Text] [Related]
20. SP-D, KL-6, and HTI-56 levels in children with mycoplasma pneumoniae pneumonia.
Shu LH; Lu Q; Han LY; Dong GH
Int J Clin Exp Pathol; 2015; 8(9):11185-91. PubMed ID: 26617840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]